• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Effect of Dorzolamide-timolol Eye drop on Intraocular Pressure Change in Intravitreal Ranibizumab Injected Patients.多佐胺-噻吗洛尔滴眼液对玻璃体内注射雷珠单抗患者眼压变化的影响。
Middle East Afr J Ophthalmol. 2024 Jun 14;30(2):85-88. doi: 10.4103/meajo.meajo_177_23. eCollection 2023 Apr-Jun.
2
Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous depressant (Timolol-Dorzolamide).辅助局部应用水性降压剂(噻吗洛尔-多佐胺)延长单次玻璃体内注射贝伐单抗的作用时间
Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):35-42. doi: 10.1007/s00417-008-0917-1. Epub 2008 Aug 6.
3
Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case-control study.预防性降眼压药物(布林佐胺)对玻璃体内注射雷珠单抗后眼压的影响:一项病例对照研究。
Indian J Ophthalmol. 2016 Oct;64(10):762-766. doi: 10.4103/0301-4738.195006.
4
Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension.多佐胺/噻吗洛尔或布林佐胺/噻吗洛尔预防对玻璃体内抗VEGF注射所致眼压升高的影响。
Semin Ophthalmol. 2013 Mar;28(2):61-7. doi: 10.3109/08820538.2012.754479.
5
Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection.局部降压药物对预防玻璃体腔注射后眼压升高的作用。
Eur J Ophthalmol. 2013 May-Jun;23(3):277-83. doi: 10.5301/ejo.5000159. Epub 2012 Nov 15.
6
EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE-TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.辅助局部多佐胺-噻吗洛尔治疗对血管内皮生长因子治疗抵抗的新生血管性年龄相关性黄斑变性患者的疗效。
Retina. 2019 Oct;39(10):1953-1958. doi: 10.1097/IAE.0000000000002293.
7
Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry.使用回弹式眼压计监测玻璃体内注射雷珠单抗后的眼压变化。
Ophthalmic Physiol Opt. 2014 Jul;34(4):438-44. doi: 10.1111/opo.12134. Epub 2014 Apr 14.
8
Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting.在现实环境中,接受玻璃体内注射抗血管内皮生长因子治疗糖尿病性黄斑水肿的眼睛出现持续性眼压升高。
Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2165-2171. doi: 10.1007/s00417-017-3782-y. Epub 2017 Aug 22.
9
[Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].[玻璃体内注射所致眼压峰值预防性治疗的疗效]
J Fr Ophtalmol. 2012 Oct;35(8):614-21. doi: 10.1016/j.jfo.2012.02.009. Epub 2012 Jul 23.
10
The effect of combination therapy with intravitreal bevacizumab and topical timolol-dorzolamide eye drops on diabetic macular edema: a double-blind randomized controlled trial.玻璃体腔内注射贝伐单抗联合局部噻吗洛尔-多佐胺滴眼治疗糖尿病黄斑水肿的疗效:一项双盲随机对照临床试验。
Int Ophthalmol. 2024 Feb 20;44(1):101. doi: 10.1007/s10792-024-03005-z.

本文引用的文献

1
Assessment of patient pain experience during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injection.玻璃体内27G贝伐单抗和30G雷珠单抗注射期间患者疼痛体验的评估。
Korean J Ophthalmol. 2015 Jun;29(3):190-4. doi: 10.3341/kjo.2015.29.3.190. Epub 2015 May 20.
2
ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS.玻璃体内注射后针头尺寸、注射后反流与眼压峰值之间的关联
Retina. 2015 Jul;35(7):1401-6. doi: 10.1097/IAE.0000000000000476.
3
Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.接受玻璃体内抗血管内皮生长因子治疗的眼睛中持续性眼压升高的预测因素。
Am J Ophthalmol. 2014 Aug;158(2):319-327.e2. doi: 10.1016/j.ajo.2014.04.029. Epub 2014 May 6.
4
Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease.眼内抗血管内皮生长因子治疗眼部新生血管疾病的全身和眼部安全性。
Surv Ophthalmol. 2011 Mar-Apr;56(2):95-113. doi: 10.1016/j.survophthal.2010.08.006.
5
Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.预防性降眼压药物对玻璃体内注射后眼压峰值的影响。
Arch Ophthalmol. 2010 Dec;128(12):1523-7. doi: 10.1001/archophthalmol.2010.297.
6
Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab.溴莫尼定/噻吗洛尔固定复方制剂对预防玻璃体内注射雷珠单抗后短期眼压升高的作用。
Klin Monbl Augenheilkd. 2010 Apr;227(4):280-4. doi: 10.1055/s-0029-1245201. Epub 2010 Apr 20.
7
Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application.注射技术对玻璃体内应用雷珠单抗后眼压升高的影响。
Graefes Arch Clin Exp Ophthalmol. 2010 Oct;248(10):1371-5. doi: 10.1007/s00417-010-1382-1. Epub 2010 Apr 21.
8
Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure.雷珠单抗(Lucentis)玻璃体内注射对眼内压的短期影响。
J Glaucoma. 2009 Dec;18(9):658-61. doi: 10.1097/IJG.0b013e31819c4893.
9
Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis).玻璃体内注射0.05毫升雷珠单抗(Lucentis)后的眼压变化过程。
Eur J Ophthalmol. 2010 Jan-Feb;20(1):174-9. doi: 10.1177/112067211002000124.
10
Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.玻璃体内注射抗血管内皮生长因子药物后立即出现的短期眼压变化。
Am J Ophthalmol. 2008 Dec;146(6):930-4.e1. doi: 10.1016/j.ajo.2008.07.007. Epub 2008 Sep 5.

多佐胺-噻吗洛尔滴眼液对玻璃体内注射雷珠单抗患者眼压变化的影响。

The Effect of Dorzolamide-timolol Eye drop on Intraocular Pressure Change in Intravitreal Ranibizumab Injected Patients.

机构信息

Department of Ophthalmology, Karabuk University Faculty of Medicine, Karabuk, Turkiye.

出版信息

Middle East Afr J Ophthalmol. 2024 Jun 14;30(2):85-88. doi: 10.4103/meajo.meajo_177_23. eCollection 2023 Apr-Jun.

DOI:10.4103/meajo.meajo_177_23
PMID:39006931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11238931/
Abstract

PURPOSE

The objective of the study was to examine the effect of dorzolamide-timolol (DT) eye drop used before intravitreal ranibizumab (IVR) injection on intraocular pressure (IOP) change.

METHODS

50 eyes of 50 patients who received DT eye drops 1 h before IVR injection due to diabetic retinopathy and macular edema were considered Group 1, and 50 eyes of 50 patients who did not receive DT eye drops were considered Group 2. Those patients who had previously undergone intravitreal injection had intraocular surgery, and used any eye drops were not included in the study. Before the injection, IO values were measured with a Tonopen contact handheld tonometer before the blepharostat was placed (BIOP), after the blepharostat was placed (AIOP), and at the 1 min after the injection (IIOP).

RESULTS

There were 25 males and 25 females in Group 1 and 25 males and 25 females in Group 2; the mean age was 65.66 ± 9.94 years in Group 1 and 65.54 ± 7.43 years in Group 2 ( = 0.98). In Group 1, BIOP was 18.91 ± 18.91, AIOP was 21.62 ± 6.16 mmHg, and IIOP was 49.21 ± 10.95 mmHg. In Group 2, BIOP was 20.18 ± 4.19 mmHg, AIOP was 24.60 ± 4.90 mmHg, and IIOP was 49.96 ± 9.72 mmHg. IIOP-BIOP difference was 30.30 ± 9.85 mmHg in Group 1 and 29.78 ± 9.33 mmHg in Group 2 and the difference was not statistically significant ( = 0.78). In Group 1, the IIOP-AIOP difference was 27.58 ± 10.60 mmHg and in Group 2, 25.36 ± 10.46 mmHg. The difference between IIOP and AIOP was not statistically significant ( = 0.27).

CONCLUSION

The use of topical DT eye drops before IVR injection does not affect the intraocular pressure change.

摘要

目的

本研究旨在探讨在玻璃体内注射雷珠单抗(IVR)前使用多佐胺-噻吗洛尔(DT)滴眼剂对眼压(IOP)变化的影响。

方法

因糖尿病视网膜病变和黄斑水肿而在 IVR 注射前使用 DT 滴眼剂 1 小时的 50 只眼(50 例患者)被归入第 1 组,未使用 DT 滴眼剂的 50 只眼(50 例患者)归入第 2 组。那些之前已经接受过玻璃体内注射、眼部手术或使用过任何眼药水的患者都不包括在研究范围内。在注射前,使用 Tonopen 接触式手持眼压计测量下睑器放置前(BIOP)、放置后(AIOP)和注射后 1 分钟(IIOP)的眼内压值。

结果

第 1 组有 25 名男性和 25 名女性,第 2 组有 25 名男性和 25 名女性;第 1 组的平均年龄为 65.66 ± 9.94 岁,第 2 组为 65.54 ± 7.43 岁( = 0.98)。第 1 组 BIOP 为 18.91 ± 18.91mmHg,AIOP 为 21.62 ± 6.16mmHg,IIOP 为 49.21 ± 10.95mmHg。第 2 组 BIOP 为 20.18 ± 4.19mmHg,AIOP 为 24.60 ± 4.90mmHg,IIOP 为 49.96 ± 9.72mmHg。第 1 组 IIOP-BIOP 差值为 30.30 ± 9.85mmHg,第 2 组为 29.78 ± 9.33mmHg,差异无统计学意义( = 0.78)。第 1 组 IIOP-AIOP 差值为 27.58 ± 10.60mmHg,第 2 组为 25.36 ± 10.46mmHg。IIOP 与 AIOP 之间的差异无统计学意义( = 0.27)。

结论

在 IVR 注射前使用局部 DT 滴眼剂不会影响眼压变化。